| Bone Tissue Engineering Materials | Lifetime | 206 | CN 43 | 99.17 |
| Silk-based biomaterials and applications | Lifetime | 117 | CN 25 | 97.86 |
| Mesenchymal stem cell research | Lifetime | 331 | CN 34 | 98.32 |
| Electrospun Nanofibers in Biomedical Applications | Lifetime | 621 | CN 200 | 97.92 |
| Periodontal Regeneration and Treatments | Lifetime | 310 | CN 15 | 97.98 |
| Tissue Engineering and Regenerative Medicine | Lifetime | 702 | CN 79 | 96.50 |
| Wound Healing and Treatments | Lifetime | 867 | CN 95 | 95.28 |
| Antioxidants, Aging, Portulaca oleracea | Lifetime | 30 | CN 13 | 90.48 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 525 | CN 165 | 81.28 |
| Hydrogen's biological and therapeutic effects | Lifetime | 597 | CN 176 | 77.61 |
| MicroRNA in disease regulation | 2021-2025 | 283 | CN 177 | 96.53 |
| Electrospun Nanofibers in Biomedical Applications | 2021-2025 | 239 | CN 133 | 96.64 |
| Wound Healing and Treatments | 2021-2025 | 147 | CN 89 | 96.27 |
| Extracellular vesicles in disease | 2021-2025 | 312 | CN 191 | 95.17 |
| Silk-based biomaterials and applications | 2021-2025 | 99 | CN 58 | 93.30 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 450 | CN 194 | 91.14 |
| Mesenchymal stem cell research | 2021-2025 | 291 | CN 97 | 91.35 |
| Cancer Mechanisms and Therapy | 2021-2025 | 178 | CN 70 | 89.88 |
| Surgical Sutures and Adhesives | 2021-2025 | 122 | CN 74 | 84.33 |
| Cancer Research and Treatments | 2021-2025 | 579 | CN 241 | 83.21 |
| Osteoarthritis Treatment and Mechanisms | 2021-2025 | 932 | CN 318 | 85.58 |
| Cancer Diagnosis and Treatment | 2021-2025 | 701 | CN 66 | 77.51 |
| S100 Proteins and Annexins | 2021-2025 | 361 | CN 55 | 74.79 |
| Medical Imaging and Pathology Studies | 2021-2025 | 908 | CN 126 | 73.79 |
| Bone Metabolism and Diseases | 2021-2025 | 763 | CN 345 | 73.20 |
| Hemostasis and retained surgical items | 2021-2025 | 163 | CN 108 | 71.31 |
| Liver physiology and pathology | 2021-2025 | 824 | CN 354 | 68.61 |
| Antimicrobial agents and applications | 2021-2025 | 729 | CN 348 | 62.98 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 688 | CN 185 | 61.74 |
| Spinal Hematomas and Complications | 2021-2025 | 453 | CN 81 | 59.86 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 987 | CN 210 | 54.56 |
| Axon Guidance and Neuronal Signaling | 2021-2025 | 343 | CN 52 | 54.01 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 656 | CN 197 | 39.95 |
